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Abstract. Serum-stimulated mouse embryo fibroblasts specifically secrete two proteins of 
molecular weights 48,000 and 26,000. The 48 kDa protein showed affinity to concanavalin 
A and was precipitated by antibody to plasminogen activator inhibitor. Immunoflow- 
cytometry using anti plasminogen activator inhibitor-1 serum indicate the presence of the 
48 kDa protein in quiescent cells; this protein was virtually absent in serum-stimulated 
cells. The presence of the plasminogen activator inhibitor-1 related protein in quiescent 
cells and its absence in serum-stimulated cells in combination with the observation on the 
absence of this protein, in the medium of quiescent cells and its presence in the medium of 
stimulated cells indicate that the 48 kDa protein was transferred from the cells into the 
medium upon serum-stimulation. The serum-mediated transfer of plasminogen activator 
inhibitor-1 from the cells into the medium was inhibited by actinomycin-D suggesting that 
the transfer process required actinomycin-D sensitive events. Treatment of pre-labelled 
quiescent cells with medium containing 20% fetal calf serum resulted in the gradual 
transfer of the labelled 48 kDa protein to the extra cellular matrix. These studies indicate 
that exposure of quiescent cells to fetal calf serum results in the transfer of plasminogen 
activator inhibitor-1 from the cells to the growth medium via extracellular matrix. The 
translocation of the protease inhibitor from the cells to the matrix and medium may enable 
the cellular and possibly the membrane proteases to act on growth factors or their 
receptors thereby initiating the mitogenic response.
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Introduction 
 
The mechanisms controlling eukaryotic cell growth and the role of proteases and
their inhibitors in growth control remain poorly elucidated. Its understanding
requires detailed knowledge of the biochemical events that occur when a 
proliferative response is induced by physiological stimuli. The interaction of growth 
factors with specific surface receptors on resting or Go phase cells rapidly induces a 
cascade of biochemical events including the formation of phosphoinositide 
metabolites, phosphorylation of proteins and a transient increase of intracellular 
pH and free Ca2+ levels (Rozengurt, 1986). One or more of these biochemical 
events are thought to generate signals within the nucleus that activate a set of 
specific growth related genes resulting at the onset of DNA replication (Lau and 
Nathans, 1985; Denhardt et al., 1986).
Secreted proteins play an important role in the regulation of cell proliferation. 
The secreted proteins fibronectin and collagens are extracellular matrix proteins 
 
 
Abbreviations used: Mr, Molecular weight; ConA, concanavalin A; PAI-1, plasminogen activator 
inhibitor-1; MEM, minimum essential medium; FCS, fetal calf serum; ECM, extra cellular matrix; BSA, 
bovine serum albumin; SDS, sodium dodecyl sulphate.
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involved in the attachment of the cells to the substratum (Yamada et al., 1985), 
while secreted proteases like collagenase and plasminogen activators and their 
inhibitors are involved in the turnover of matrix components and in tumor cell 
invasion (Bauer et al., 1985; Hart and Rehemtulla, 1988; Moscateli and Rifkin 
1988). In addition, secretion of growth inhibitors and growth factors were observed 
at different stages of cell growth and development (Nilsen–Hamilton and Hamilton, 
1982; Harel et al., 1985; Hsu and Wang 1986; Nagashunmugam and Shanmugam, 
1987). Cell surface proteinases are shown to be important in growth and division of 
normal and transformed cells and the role of proteinases and their inhibitors in 
eukaryotic cell growth has been reviewed by Scott (1987). The secretion and 
deposition of proteases such as plasminogen activators (PA) and their inhibitors 
such as protease nexins and plasminogen activator inhibitors in the extracellular 
matrix suggest the possibility of cellular self regulation by growth related 
proteinases and their inhibitors (Laiho and Keski-Oja, 1989).
In the studies reported here, we have identified and characterized a serum- 
induced secreted protein of molecular weight (Mr) 48,000. This protein is specifically 
present in the growth medium of serum-stimulated cells but not in the medium of 
quiescent cells. Immunoprecipitation and concanavalin A (Con A) binding studies 
indicate that this protein is related to endothelial cell type plasminogen activator 
inhibitor (PAI-1). Evidence is provided for the translocation of the 48 kDa protein 
from the quiescent cells to the growth medium upon serum-stimulation.
 
Materials and methods 
 
Cell culture 
 
Secondary cultures of Swiss mouse embryo fibroblasts were maintained at 37°C in
minimum essential medium (MEM) of Eagle (Flow Labs, UK) containing 10%
bovine serum (Flow Labs, UK) and gentamycin 50 µg/ml. Cells from the fourth 
passage and above were used for experiments. Cells were synchronized at 
quiescence by maintaining sub-confluent monolayers in 0·5% serum containing 
medium for 72 h. Cells were released from quiescence by the addition of 20% fetal 
calf serum (FCS) containing medium. Serum-stimulation period was 6 h unless 
otherwise mentioned. 
 
Radiolabelling of proteins 
 
Quiescent and stimulated monolayers (120 cm2) were pulse-labelled with 50 µCi of 
[35S] methionine (Amersham, specific activity 10·7 Ci/µmol) for 30 min in 5 ml of 
Hank’s balanced salt solution. At the end of labelling, the medium was removed 
and the monolayer was washed thrice with MEM. The radioactivity was chased by 
incubating the monolayers for 30 min in serum-free medium. After the chase, the 
medium was saved for the analysis of secreted proteins. The extracellular matrix 
(ECM) proteins were isolated as described by Laiho et al. (1986). The secreted and 
ECM proteins were processed for electrophoresis as described earlier 
(Nagashunmugam et al., 1989). Briefly, the conditioned medium containing equal 
amounts of radioactivity were precipitated with 10% trichloroacetic acid in the 
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presence of 50 µg of bovine serum albumin (BSA) and kept at 4°C for 30 min. The 
samples were centrifuged at 15,000 g for 20 min and the protein precipitate was air 
dried, dissolved in 0·1 Ν NaOH and then mixed with equal volume of 2 × 
electrophoresis sample buffer. 
 
Analysis of cellular fluorescence 
 
The intracellular content of PAI-1 in quiescent, and serum-stimulated cells was 
quantitated using PAI-1 antiserum obtained from Dr. David Loskutoff, Scripps 
Clinic, San Diego, USA. FITC conjugated anti-rabbit IgG was used as second 
antibody and the fluorescence was quantitated in a fluorescence activated cell 
scanner (Becton Dickinson) as described earlier (Nagashunmugam et al., 1989).
 
Immunoprecipitation 
 
Immunoprecipitation of secreted and ECM proteins were carried out following the 
procedure of Chackalaparampil et al. (1985). Labelled medium (10 ml) containing 
secreted proteins from serum stimulated cells were concentrated to 0·5 ml by 
ultrafiltration and made up to 1 ml in RlPA buffer [0·1 % Triton X-100, 1% sodium 
deoxy cholate, 0·1 % sodium dodecyl sulphate (SDS), 0·15 Μ NaCl, 2mM 
phenylmethylsulphonyl fluoride and 0·05 Μ Tris-HCl pH 7·2] and centrifuged at 
10,000 g for 20 min. The extracellular matrix proteins were collected in R1PA buffer 
and centrifuged at 10,000 g for 20 min. To the 10,000 g supernatants 10µl of anti 
PAI-1 serum was added and the mixtures were incubated at 37°C for 30 min and 
then kept at 4°C overnight. The antigen-antibody complexes were treated with an 
excess of protein A sepharose (30 µl of 50% slurry in Rl PA buffer) at 4°C for 6–8 h. 
The absorbed complex was washed once with RIPA buffer thrice with washing 
buffer (50 mM Tris-HCl pH 7·4, 5% sucrose, 1% Nonidet P-40, 0·5 Μ NaCl and 
5 mM EDTA) and finally with distilled water. The immune complexes along with 
protein A sepharose were subsequently suspended in 50 µl of electrophoresis sample 
buffer and heated at 100°C for 3 min. The sepharose beads were pelleted and the 
proteins in the supernatant were electrophoresed in 5–18% SDS-polyacrylamide 
gradient gels. 
 
Gel electrophoresis and autoradiography 
 
Intracellular and secreted proteins of quiescent and serum-stimulated cells were 
separated on high resolution SDS polyacrylamide gradient (5–18%) gels containing
6% stacking gels (Laemmeli and Favre, 1973). The protein samples were prepared 
in electrophoresis sample buffer and samples derived from equal amounts of cells 
were electrophoresed. Following electrophoresis, gels were stained with Coomassie 
blue and fluorographed (Bonner and Laskey, 1974). For the determination of 
molecular weights of the labelled polypeptides, molecular weight markers 
(Rajakumar and Shanmugam, 1983) were electrophoresed in parallel lanes and 
 stained. The fluorogram was super-imposed over the dried gel containing stained 
marker proteins to determine the relative mobilities of the proteins. The molecular 
weights of the proteins were subsequently determined as described earlier 
(Rajakumar and Shanmugam, 1983).
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Results 
 
Secreted proteins of serum-stimulated and starved cells 
 
Two proteins of Mr 48,000 and 26,000 were specifically secreted by quiescent cells in 
response to serum-stimulation (figure 1A). The 48 kDa secreted protein was absent 
in the conditioned medium of quiescent cells. However, high levels of this protein 
were present in the medium of stimulated cells. During the reverse process (serum- 
starvation), the level of the 48 kDa protein in the growth medium slowly declined 
(figure 1B). The low levels of the 48 kDa protein in the medium of serum-starved 
cells may be due to lack of transfer of this protein from the starved cells into the 
medium. This conclusion is supported by the immunofluorescence studies described 
below. 
 
 
Figure 1. Effect of serum-stimulation (A) and serum-starvation (B) on the levels of 
secreted proteins. Q, quiescent cells; S, serum-stimulated cells; P, proliferating cells in 10% 
serum-containing medium. The numbers 24 and 48 indicate hours after shift of 
proliferating cells into serum-limiting (0·5% serum) medium. Cells were pulse labelled for 
30 min with [35S]methionine and then the radioactivity was chased for 30 min in serum- 
free chase medium. The proteins from the chase medium were electrophoresed in 5–18% 
polyacrylamide gradient gels containing SDS and fluorographed.
 
 
 
Another secreted protein of Mr 26,000 was also present in reduced levels in the 
medium of serum-starved cells in comparision to its amount in serum-stimulated 
cells (figure 1). Further studies on this protein are in progress. The 40 kDa secreted 
protein was shown to be a quiescent cell specific protein; the level of this protein 
declined in the growth medium of serum-stimulated cells (Subramaniam and 
Shanmugam, 1988).
To know whether the 48 kDa secreted protein is a glycosylated protein, ConA 
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binding studies were done. Figure 2 lane Β shows that the 48 kDa secreted protein 
and the 240 kDa fibronectin (Subramaniam and Shanmugam, 1985) were the 
predominant ConA binding proteins secreted by serum-stimulated cells. The 
48 kDa protein was also found to be a major component of the ECM (lane D). 
Since a ConA binding ECM protein of Mr 48,000 was identified as PAI-1 (van 
Mourik et al., 1984), it was of interest to know whether the 48 kDa protein with 
similar properties reported here is related to PAI-1. Immunoprecipitation assays 
using antiserum to endothelial cell type plasminogen activator inhibitor indicate 
that the 48 kDa ECM and secreted proteins are related to PAI-1 (figure 2, lanes C 
and E). 
 
 
 
Figure 2. ConA binding and immunoprecipitation. Conditioned medium of serum- 
stimulated [35S]methionine labelled cells were concentrated by ultrafiltration and aliquots 
were used for ConA binding and immunoprecipitation studies. For ConA binding, 50 µl of 
50% suspension of ConA-sepharose 4B and 0·5 ml of concentrated conditioned medium 
were mixed and left at 40C over night with intermittant shaking. The ConA bound 
proteins were isolated as described by Laiho et al. (1986) and electrophoresed in 5–18% 
polyacrylamide gradient gels. Details of immunoprecipitation are given in the ‘materials 
and methods’. A. Secreted proteins of serum-stimulated cells. B. Proteins of serum- 
stimulated cells bound to ConA-sepharose. C. Immunoprecipitate obtained using anti 
PAI-1 serum and concentrated conditioned medium from serum-stimulated cells. D. ECM 
proteins of serum-stimulated cells. E. Immunoprecipitate obtained using anti PAI-1 serum 
and ECM proteins of serum-stimulated cells. The proteins were electrophoresed in 5–18% 
polyacrylamide gradient gels containing SDS and autoradiographed.
 
 
 
Quantitation of intracellular ΡAI 
The cellular levels of PAI-1 was quantitated by immunoflow-cytometry. Cells were 
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permeabilized with 0·1% Triton X-100 and reacted first with rabbit antiserum to 
PAI-1 and then with FITC conjugated anti-rabbit IgG. The cellular fluorescence 
was monitored by a FAC scanner (Nagashunmugam et al., 1989). Quiescent cells 
treated with normal serum showed a single peak of low fluorescence (figure 3A). In 
contrast, quiescent cells reacted with an anti PAI-1 serum showed an additional 
(second) peak with higher fluorescence (figure 3B). Serum-stimulated cells treated 
with PAI-1 antibody did not show the high fluorescence (second) peak (figure 3C). 
However, serum-stimulated cells that were treated with actinomycin D (1 µg/ml) 
showed the high fluorescence peak when reacted with anti PAI-1 antibody. These 
results indicate the presence of PAI-1 in quiescent cells, its absence in serum- 
stimulated cells and its persistence in serum-stimulated cells maintained in 
actinomycin D containing medium.
 
 
Figure 3. Quantitation of intracellular levels of PAI-1. Quiescent and serum-stimulated 
cells were collected, fixed with formaldehyde and permeabilized by Triton X-100 treatment. 
The permeabilized cells were reacted with either rabbit PAI-1 antibody (B, C, D ) or 
normal rabbit serum (A). After reacting with FITC conjugated sheep anti rabbit γ-globulin, 
the fluorescence was quantitated in a FAC scanner. A, B. Quiescent cells. C. Serum- 
stimulated cells. D. Serum-stimulated cells treated with actinomycin D. 
 
 
Effect of  serum on prelabelled 48 kDa protein 
 
The absence of the 48 kDa PAI related protein in the stimulated cells while being 
present in the quiescent cells and its appearance in the medium of serum-stimulated 
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cells implies that this protein may be translocated from the quiescent cells to the 
matrix and growth medium upon mitogenic stimuli. Studies on the fate of pre- 
labelled proteins provide evidence for this hypothesis. For these studies, 4 
monolayers of MEF, each with equal number of cells were made quiescent by 
serum-starvation for 72 h. When these quiescent cells were pre-labelled for 30 min 
with [35S ] methionine and then stimulated with 20 % FCS in non-radioactive chase 
medium, substantial quantities of the labelled 48 kDa protein was found to be 
deposited in the extra cellular matrix of the serum-stimulated cells (figure 4). Laser 
 
 
Figure 4. Fate of prelabelled 48 kDa protein. Quiescent mouse embryo fibroblasts were 
labelled with [35S]methionine. After 30 min, the radioactive medium was removed, the 
monolayers were washed thrice with PBS and incubated for an hour in the conditioned 
medium obtained from quiescent cultures (Q medium). Lane 1, matrix proteins from cells 
that were maintained for an additional hour in Q medium. Lane 2, matrix proteins of cells 
that were maintained in 20% FCS containing medium for an additional hour. Lane 3, 
matrix proteins of cells that were maintained for an additional 2 h in Q medium. Lane 4, 
matrix proteins of cells that were maintained for an additional 2 h in 20% FCS containing 
medium. The matrix proteins were resolved by electrophoresis in 5-18% polyacrylamide 
gradient gels containing SDS and fluorographed.
 
 
 
densitometric quantitation of the radioactive 48 kDa protein bands shown in figure 
4 indicates an increase of about 39 % in the intensity of the band after 1 h exposure 
of pre-labelled cells to 20% serum-containing medium (lane 2). This increase was 
much higher (2·6-fold) in the matrix derived from pre-labelled cells that were treated 
for 2 h with 20% serum-containing medium (lane 4). Under the same conditions, 
the level of the pre-labelled 240 kDa protein [previously identified as fibronectin 
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(Subramaniam and Shanmugam, 1985)] in the matrix declined in the first hour of 
exposure of quiescent cells with serum and disappeared at the end of 2 h treatment 
of pre-labelled cells with serum-containing medium. While FCS treatment had a 
spectacular effect on the time dependent transfer of the 48 kDa protein, the 
disappearance of the 240 kDa protein was not influenced by treatment of quiescent 
cells with FCS (lanes 3 and 4). These studies imply that mitogenic stimulation 
triggered the transfer of PAI-1 from the cells into the matrix. Previous studies 
indicate that PAI-1 is transferred into the medium via the extracellular matrix 
(Levin and Santell, 1987).
 
Discussion 
 
In this study, we have identified a serum-induced secreted protein of Mr 48,000 as 
PAI-1. Based on the results of the presence of high levels of this protein in the 
quiescent cells and low levels in the stimulated cells, and on the absence of this 
protein in the quiescent cell conditioned medium and on its presence in the 
stimulated cell medium, we propose that the PAI-1 related 48 kDa protein is 
translocated from the quiescent cells to the growth medium upon mitogenic stimuli. 
Transfer of pre-labelled 48 kDa protein from the cell to the matrix in response to 
exposure of cells to 20% FCS confirms these results (figure 4).
We have used indirect immunofluorescence and its quantitation by fluorescence-
activated cell analyser to get an insight on the intracellular amounts of PAI-1. The 
results presented in figure 3 indicate high levels of PAI-1 specific fluorescence in 
quiescent cells. The serum-stimulated cells did not show significant levels of PAI-1 
specific fluorescence while the serum-stimulated cells treated with actinomycin D 
showed a PAI-1 specific fluorescence peak similar in magnitude as that observed in 
quiescent cells (figure 3D). The presence of PAI-1 specific peak in quiescent cells 
and its absence in serum-stimulated cells may indicate that the protein was lost by 
the stimulated cells. However, the concomitant appearance of PAI-1 in the matrix 
and medium upon serum-stimulation implies that the PAI-1 of the stimulated cell 
was transferred to the matrix and medium following serum-stimulated growth. The 
persistence of intracellular PAI-1 in serum-stimulated cells that were treated with 
actinomycin D implies that the transfer process of this protein required serum- 
stimulated actinomycin D sensitive proteins.
Exogenous and endogenous proteinases were shown to be involved in the release 
of membrane-bound mitogenic proteins (autocrine growth effectors) into the 
medium (Lieberman, 1983). The presence of these protease inhibitors at discrete 
sites may inhibit the action of proteases from triggering the mitogenic signal. 
Trypsin, thrombin and some serine proteinases initiate DNA synthesis in cultured 
cells by their action on the cell surface (Scott, 1987). Several peptide mitogens were 
found in association with esterolytic or proteolytic activities. Gospodarowicz and 
Moran (1976) have suggested that proteinases could potentiate the effect of growth 
factors by activation, or by conditioning the target cells, enabling them more 
sensitive to growth factors.
Since proteases elicit mitogenic response, removal or translocation of protease 
inhibitors from the cell may enable the action of cell associated proteases in the 
activation of peptide growth factors and their receptors. Our results on the 
translocation of PAI-1 is interesting in the light of the suggested role of PAI in the 
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inhibition of cleavage of pre-TGF-ß (Keski–Oja and Moses, 1987). Thalacker and 
Nilsen–Hamilton (1987) have shown that TGF-β and TP A induced the secretion of 
PAI-1 in a variety of cell lines. In certain cells, TGF-β is implicated in the induction 
of cellular oncogenes like c-sis, which presumably activate c-fos and c-myc genes 
culminating in DNA synthesis (Leof et al. 1986). PAI-1 may inhibit the cleavage 
and subsequent activation of TGF-ß and other growth factors by its presence in the 
quiescent cell. Translocation or removal of PAI from the quiescent cell may trigger 
the activation of growth related proteases in the quiescent cell enabling it to enter 
into the proliferating phase.
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